Kagan and Soai Win 2026 Nobel Chemistry Prize

Published: 07 October 2026. The English Chronicle Desk. The English Chronicle Online

French chemist Henri B. Kagan and Japanese scientist Kenso Soai have been awarded the 2026 Nobel Prize in Chemistry for discoveries that transformed scientists’ understanding of how chemical reactions can favour one mirror-image form of a molecule over another.

The Royal Swedish Academy of Sciences announced the award in Stockholm on Wednesday, marking the third Nobel Prize announcement of the 2026 season following the prizes in physiology or medicine and physics. Kagan and Soai were recognised “for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis”, work that has helped resolve a long-standing mystery surrounding the chemical origins of molecular handedness.

The prize highlights a fundamental feature of chemistry that is also deeply connected to life itself. Many molecules exist in two forms that are mirror images of each other, much like a person’s left and right hands. Although the two versions may look remarkably similar, they are not identical and can behave differently when interacting with other molecules.

This property is known as chirality, derived from the Greek word for hand. In living organisms, the distinction is particularly important because biological systems often use only one of the two possible mirror-image forms of a molecule.

Amino acids provide one of the clearest examples. They can exist in two mirror-image configurations, yet proteins in living organisms overwhelmingly contain only one of those forms. For generations, chemists have sought to understand how such a strong chemical preference could emerge and how it could be reproduced artificially.

The work of Kagan and Soai provided important answers to that puzzle by showing how chemical reactions can be guided towards one molecular form and how a small initial imbalance can be dramatically amplified.

Kagan, a French chemist associated with Université Paris-Sud, made a major breakthrough in the study of asymmetric synthesis. His research demonstrated ways of influencing chemical reactions so that they produce a greater proportion of one mirror-image molecule than had previously been thought possible.

That discovery became an important foundation for modern asymmetric catalysis, an area of chemistry concerned with controlling the three-dimensional arrangement of molecules produced during chemical reactions.

Soai subsequently made a landmark contribution through his research into autocatalysis. In an autocatalytic reaction, a chemical product can help accelerate the reaction that produces it. This creates the possibility of amplification, meaning that a very small initial difference between two molecular forms can become increasingly pronounced as the reaction continues.

Soai’s work eventually produced a reaction capable of generating essentially one of two possible mirror-image forms under suitable conditions. His research provided scientists with a remarkable experimental demonstration of how chemical asymmetry can emerge and become amplified without relying on biological systems.

Together, the discoveries of Kagan and Soai have helped chemists understand how homochirality can arise. Homochirality refers to the predominance of one molecular handedness in biological systems, a phenomenon that has puzzled scientists for more than a century.

The importance of the research extends well beyond theoretical chemistry. The ability to control molecular handedness is particularly important in pharmaceutical development because different mirror-image forms of the same compound can have very different effects in the human body.

One molecular form may provide the desired therapeutic effect, while its mirror image may be less effective or behave differently. In some cases, controlling the precise structure of a molecule can therefore be essential to developing medicines that are both effective and safe.

Asymmetric synthesis has consequently become a major area of modern pharmaceutical chemistry. Researchers use increasingly sophisticated catalytic techniques to produce complex molecules with greater precision, reducing the need to separate unwanted molecular forms after a chemical reaction has taken place.

The Nobel recognition of Kagan and Soai reflects how fundamental discoveries in chemistry can eventually influence practical technologies and industries. Their work has contributed to a deeper understanding of molecular reactions and has provided tools and concepts used by scientists working on the synthesis of pharmaceuticals and other complex chemical substances.

The research also offers an insight into one of the most intriguing questions surrounding the chemistry of life. Scientists have long wondered why living systems display such a strong preference for one molecular handedness. If ordinary chemical reactions tend to produce mirror-image molecules in roughly equal amounts, how did the strong asymmetry found in living organisms emerge?

There is no single answer to every aspect of that question, but the discoveries recognised by this year’s Nobel Prize demonstrate mechanisms through which a tiny chemical imbalance can be amplified. Such processes provide an important window into possible pathways through which chemical asymmetry could develop.

The Nobel Committee has described the reactions developed and studied by Kagan and Soai as significant in addressing this long-standing chemical mystery. Their work demonstrates that chemical systems can move from a small initial asymmetry towards a much stronger molecular preference through carefully controlled reaction mechanisms.

The recognition is also a reminder that major scientific advances do not always emerge from discoveries with immediate practical applications. In many cases, researchers first investigate fundamental questions about how nature works, with technological and industrial applications becoming clearer only later.

For modern chemistry, understanding and controlling molecular structure has become increasingly important. The development of advanced medicines, materials and chemical processes depends not only on knowing which atoms are present in a compound but also on understanding precisely how those atoms are arranged in three dimensions.

This is where the concept of molecular handedness becomes particularly important. Two molecules can contain the same atoms and chemical bonds while still behaving differently because their three-dimensional arrangements are mirror images.

Kagan’s and Soai’s research helped establish new ways of controlling these differences, strengthening the foundations of asymmetric organic synthesis and expanding scientists’ ability to design chemical reactions with greater selectivity.

The 2026 chemistry award also continues a long Nobel tradition of recognising discoveries that fundamentally alter scientific understanding. The chemistry prize has frequently honoured work that initially appears highly specialised but later becomes essential to medicine, industry or wider scientific research.

Kagan and Soai will receive their Nobel medals and prize at the traditional Nobel ceremonies in Stockholm on 10 December, the anniversary of Alfred Nobel’s death. The chemistry laureates will share a prize of 12 million Swedish kronor.

The Nobel celebrations will continue throughout the week, with the literature and peace prizes scheduled to follow the announcements in chemistry. The Nobel Prize in Economic Sciences will be announced later in the month.

For the scientific community, however, Wednesday’s announcement is particularly significant because it shines a spotlight on a problem that sits at the intersection of fundamental chemistry, the origins of biological asymmetry and modern pharmaceutical science.

The discoveries of Henri B. Kagan and Kenso Soai show how seemingly subtle differences at the molecular level can have profound consequences. By demonstrating how chemical reactions can favour and amplify one mirror-image form, their work has given researchers a powerful framework for understanding one of chemistry’s most enduring puzzles.

Their Nobel Prize therefore recognises not only two distinguished careers but also a broader scientific achievement: revealing how molecular handedness can emerge, be amplified and ultimately be controlled.

In a field where the smallest structural difference can change the behaviour of an entire molecule, that insight has proved both scientifically profound and practically valuable. The 2026 Nobel Prize in Chemistry places that achievement at the centre of global scientific attention and underscores the continuing importance of fundamental research in shaping the future of medicine and chemical science.